Business Standard

Granules India surges 6% on Carlyle group acquisition buzz

Carlyle is expected to buy 42 per cent of promoter shares, which will trigger an open offer to acquire additional stake from others, CNBC TV18 report.

Granules India bags exclusive rights for USpharma Windlas' four products
Premium

SI Reporter Mumbai
Shares of Granules India surged 6 per cent and hit a new high of Rs 438 on the BSE on Tuesday as media reports suggested that private equity firm Carlyle group is in advanced stages to acquire the pharmaceutical firm for around $1 billion.

Carlyle is expected to buy 42 per cent of promoter shares, which will trigger an open offer to acquire additional stake from others, CNBC TV18 reported.

On September 25, 2020, Granules India said that we hereby inform you that we do not confirm or deny the information contained in the aforementioned news article. If

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in